Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways.

Education

Pharmaceutical

Sagimet Biosciences

David Happel

Anthony Rimac

Elizabeth Rozek

Katharine Grimmer

Wen-Wei Tsai

Marie O’Farrell

Eduardo Bruno Martins

The Scientific Team at Sagimet Biosciences is responsible for advancing the company's drug development pipeline by conducting cutting-edge research, designing and overseeing clinical trials, and providing strategic scientific insights to target dysfunctional metabolic pathways in diseases like NASH and specific cancers. They collaborate closely to translate innovative therapeutic concepts into clinical-stage treatments.

Scientific Team

Directors Team

Leadership Team

Scientific Team

About

Team members

Other teams at Sagimet Biosciences

Directors Team

Leadership Team